The North America Mobile Cardiac Telemetry Systems Market would witness market growth of 10.5% CAGR during the forecast period (2020-2026).
Mobile cardiac telemetry (MCT) devices are small portable sensors worn by patients for cardiac rhythm monitoring. If an anomaly is detected in the heart rhythm, the sensor records it and sends the data to the transmitter which transmits the data to the manned monitoring center using a mobile network. The results submitted to the reporting center were reviewed by qualified healthcare practitioners for recommendations to doctors or patients for further diagnosis. Real-time data provided by mobile cardiac telemetry systems provide an edge over other cardiac monitoring systems, such as Holter monitoring systems or event monitoring systems.
Growing awareness of emerging patch technology and the introduction of innovative devices with optimized applications are the main factors driving the development of the global demand for mobile cardiac telemetry systems. The U.S. market recorded maximum revenue share due to the existence of top suppliers of mobile devices, improved R&D, and a significant pool of adult patients with cardiac and other heart conditions.
North America dominated the market for mobile cardiac telemetry. This growth is attributable to multiple factors like the increasing geriatric population, the prevalence of cardiac disorders, and rising healthcare costs. For example, according to a survey released by the Community Living Administration, the geriatric population of the United States has increased exponentially. In addition, the involvement of major service providers with advanced healthcare technologies is projected to boost market growth during the forecast period.
Based on Application, the market is segmented into Lead based and Patch Based. Based on End User, the market is segmented into Hospitals, Cardiac centers and Other End-user. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc. (Welch Allyn), Asahi Kasei Corporation (Zoll Medical Corporation), ScottCare Corporation (Berkshire Hathway, Inc.), iRhythm Technologies, Inc., Biotricity, Inc., G Medical Innovations Holdings Ltd. (Telerhythmics LLC), BioTelemetry, Inc., Applied Cardiac Systems, Inc., Medicomp, Inc., and Preventice Solutions, Inc.
Scope of the Study
Market Segmentation:
By Application

  • Lead based and
  • Patch Based


By End User

  • Hospitals
  • Cardiac centers and
  • Other End-user


By Country

  • US
  • Canada
  • Mexico
  • Rest of North America


Companies Profiled

  • Hill-Rom Holdings, Inc. (Welch Allyn)
  • Asahi Kasei Corporation (Zoll Medical Corporation)
  • ScottCare Corporation (Berkshire Hathway, Inc.)
  • iRhythm Technologies, Inc.
  • Biotricity, Inc.
  • G Medical Innovations Holdings Ltd. (Telerhythmics LLC)
  • BioTelemetry, Inc.
  • Applied Cardiac Systems, Inc.
  • Medicomp, Inc.
  • Preventice Solutions, Inc.


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free